Our Cofounder and Chief Data Science Officer, Dr. Layla Hosseini-Gerami has been named to Forbes's 30 Under 30 Europe Class of 2025 in Science & Healthcare.
"Using AI, Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects. The company identifies drug candidates that face safety concerns and are typically 80 to 90 percent on the way to success, and then uses a combination of AI and deep scientific expertise to determine the underlying issues and develop solutions. Cofounded by Dr. Layla Hosseini-Gerami with Dr. Jordan Lane and Sam Windsor (both over 30), Ignota Labs secured a $6 million seed in February 2025 to advance into early-stage clinical trials of their first asset, a PDE9A inhibitor, a metabolic health drug for post-menopausal women."
Read more:
The 30 under 30 list for Science & Healthcare can be read in full at Forbes.
Published: 15 April 2025 by Forbes Media.
